Testing effectiveness (Phase 2)Study completedNCT00337129
What this trial is testing
S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 42